Immunovant Inc (NQ: IMVT )
Price and Volume
Detailed QuoteVolume | 2,423,772 |
Open | 36.18 |
Bid (Size) | 36.22 (1) |
Ask (Size) | 38.14 (10) |
Prev. Close | 36.01 |
Today's Range | 36.16 - 40.00 |
52wk Range | 12.40 - 44.19 |
Shares Outstanding | 114,998,871 |
Dividend Yield | N/A |
Top News
More News
Where Immunovant Stands With Analysts
November 15, 2023
Performance
More News
Read More
Recap: Immunovant Q2 Earnings
November 09, 2023
Benzinga's Top Ratings Upgrades, Downgrades For October 13, 2023
October 13, 2023
The Latest Analyst Ratings for Immunovant
October 09, 2023
Immunovant Inc. (NASDAQ: IMVT) Records 52-Week High Tuesday Morning
September 26, 2023
Lamb Weston, SP Plus And Other Big Stocks Moving Higher On Thursday
October 05, 2023
What's Going On Pfizer's Subsidiary Biohaven Stock?
September 27, 2023
Biohaven, Yet Another Argenx Rival In Autoimmune Drugs, Just Rocketed 29%
September 27, 2023
Why Immunovant Stock Is Bolting Higher Today
September 27, 2023
Immunovant Parlays Its Shot At Rivaling Argenx Into A $300 Million Offering
September 27, 2023
Roivant Stock Price Outlook: Strong Pipeline Is A Catalyst
September 27, 2023
Benzinga's Top Ratings Upgrades, Downgrades For September 27, 2023
September 27, 2023
Why Shares of Immunovant Are Soaring on Tuesday
September 26, 2023
Nasdaq Down 1.5%; Immunovant Shares Spike Higher
September 26, 2023
12 Health Care Stocks Moving In Tuesday's Intraday Session
September 26, 2023
Crude Oil Moves Higher; Cintas Earnings Top Estimates
September 26, 2023
Why Is Autoimmune Disease-Focused Immunovant Stock Trading Higher Today?
September 26, 2023
These 2 Biotech Stocks Are Bucking a Down Market Tuesday
September 26, 2023
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
September 26, 2023
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.